| Literature DB >> 20938453 |
Kim M Pepin1, Sandra Lass, Juliet R C Pulliam, Andrew F Read, James O Lloyd-Smith.
Abstract
Adaptation is often thought to affect the likelihood that a virus will be able to successfully emerge in a new host species. If so, surveillance for genetic markers of adaptation could help to predict the risk of disease emergence. However, adaptation is difficult to distinguish conclusively from the other processes that generate genetic change. In this Review we survey the research on the host jumps of influenza A, severe acute respiratory syndrome-coronavirus, canine parvovirus and Venezuelan equine encephalitis virus to illustrate the insights that can arise from combining genetic surveillance with microbiological experimentation in the context of epidemiological data. We argue that using a multidisciplinary approach for surveillance will provide a better understanding of when adaptations are required for host jumps and thus when predictive genetic markers may be present.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20938453 PMCID: PMC7097030 DOI: 10.1038/nrmicro2440
Source DB: PubMed Journal: Nat Rev Microbiol ISSN: 1740-1526 Impact factor: 60.633
Figure 1Mechanisms of viral emergence in new hosts.
Host jumps and associated genetic diversity can arise through a range of ecological and evolutionary mechanisms. a | Ecological driver with founder effects. Any of the viral genotypes circulating in the reservoir are already competent for transmission in the new host; the basic reproductive number (R0) of the virus strains in the reservoir and the new host are > 1. Following host jump, neutral mutations occur during replication and transmission in the new host population. The combination of founder effects and neutral mutation result in a shifted distribution of viral genotypes in the new host, which each have R0 > 1. b | Ecological driver with adaptive fine-tuning. The circulating viral genotypes that spill over are already adapted for transmission to the new host (R0 > 1), but adaptive substitutions occur owing to long-term selection in the new host even though they were not required for the initial emergence, such that the R0 of the adapted virus is greater than the R0 of the virus that initially spilled over. c | Adaptive mutation in an unadapted genotype. The reservoir strain that causes emergence has R0 < 1 in the new host and requires additional genetic change to reach R0 > 1. The change could occur in the initial host individual in whom spillover occurred or during stuttering transmission. Some genotypes will possess a genetic or phenotypic predisposition to acquire the necessary adaptive mutations and achieve R0 > 1, which makes them more likely to emerge. These strains are predictors of emergence risk. d | Spillover of a fortuitously adapted genotype. The genotype that spills over and causes emergence already has R0 > 1 in the new host, unlike other viral genotypes circulating in the reservoir population. Scenarios b and d differ because in d some genotypes in the reservoir host can establish in the new host, whereas others cannot; in b, the genotype composition in the reservoir host is not a predictor of emergence.
The role of adaptation in host jumps to humans for selected zoonotic viruses
| Zoonotic pathogen (zoonotic stage*) | Reservoir hosts | Sources of transmission to humans | Emergence mechanism† | Evidence for or against |
|---|---|---|---|---|
| SARS-CoV (IV) | Bats (putative) | Palm civets | A | Against: convergent sequence evolution suggests adaptation did occur |
| B | Against: adaptation was necessary •Repeated independent cross-species transmission to humans followed by limited on-going transmission •All human isolates had numerous non-synonymous mutations not observed in palm civet isolates •Some of these mutations improve the ability of palm civet virus isolates to reproduce in cultured cells bearing human receptors | |||
| C and D | Cannot distinguish between C and D; more intensive sampling from palm civets and humans around the time of initial spillover is required | |||
| Ebola virus Zaire (IV) | Fruit bats (putative) | Wild apes, duiker (speculated) and unknown host | A–D | Insufficient sampling of virus in wildlife and along chains of human–human transmission |
| H5N1 influenza A virus (III) | Wild birds and domestic poultry | Domestic poultry | A and B | Against: repeated independent cross-species transmission to humans followed by little or no ongoing transmission suggest that genetic types predominant in the reservoir host have R0 < 1 in humans and that an adaptive driver is required for a host jump |
| C and D | Cannot distinguish between C and D; genetic surveillance in the reservoir species and along chains of human–human transmission is necessary | |||
| Nipah virus Bangladesh (III) | Fruit bats | Fruit bats (through contaminated date palm sap) and domestic animals (speculated) | A and B | Against: repeated independent cross-species transmission to humans followed by limited ongoing transmission suggests that genetic types predominant in the reservoir host have R0 < 1 in humans and that an adaptive driver is required for a host jump |
| C and D | Cannot distinguish between C and D; greater understanding of potential genetic markers of adaptation is necessary | |||
| Monkeypox virus (III) | Unknown | Prairie dogs (USA), rope squirrels (speculated; Africa) and monkeys (Africa) | A and B | Against: repeated independent cross-species transmission to humans followed by limited ongoing transmission suggests that genetic types predominant in the reservoir host have R0 < 1 in humans and that an adaptive driver is required for a host jump |
| For: transmission of monkeypox among humans may be severely curtailed because of protective antibodies from past smallpox vaccination; increasing incidence of monkeypox in humans has been observed as population-level antibody prevalence has declined, possibly allowing sustained human–human transmission without viral genetic changes | ||||
| C and D | Cannot distinguish between C and D; greater understanding of potential genetic markers of adaptation is necessary | |||
| VEEV (II) | Rodents | Horses (by mosquitoes) | A and B | Against: •Repeated independent cross-species transmission to humans with no evidence of ongoing transmission suggests that genetic types predominant in the source host have R0≈1 in humans and that an adaptive driver is required for a host jump •Adaptation seems to be required for successful emergence in horses |
| C and D | Cannot distinguish between C and D; greater understanding of potential genetic markers§ of adaptation is necessary. *Stage I: animal pathogen with no evidence of transmission to humans (not included here). Stage II: transmission to humans occurs with no evidence for subsequent chains of human–human transmission. Stage III: cross-species transmission to humans is followed by human–human transmission with 0 < R0 < 1. Stage IV: cross-species transmission to humans is followed by epidemic or pandemic human–human transmission with R0 > 1. Stage V: cross-species transmission in the past produced a new endemic human pathogen (not included here)[ |
Steps of investigation of examining viral host jumps*
| Sample viruses | Animal models | Reservoir and new hosts | |
|---|---|---|---|
|
| |||
• Sampling of opportunistically viruses from reservoir and/or new host (including important host data such as species and location) • Consensus sequencing of viral genes and genomes • Use of nucleotide-based bioinformatics to identify genetic markers of host specificity and adaptation[ | • Antigenic characterization (for example, haemagglutination-inhibition assays) • Introduction of putative adaptive mutations in wild-type strain and removal of adaptive mutation from adapted virus[ • Receptor binding and infectivity assays in cells expressing the viral receptor of the new host[ • Polymerase activity or replication rate assays[ | • Infections with a single strain • Determination of viral fitness by measuring within-host fitness, tissue tropism, pathogenicity and virulence | • Measurement of viral traits in either the reservoir or the new host using viral genotypes (and/or recombinants) from the reservoir or new host population from one host-jump event[ |
|
| |||
• Systematic sampling of viral populations cross-sectionally and longitudinally from many individuals and new host populations • Sequencing of many clones from each viral population • Integration of protein structure prediction, phylogenetic analyses and/or protein-based bioinformatics to identify host-jump markers that are under selection[ • Collection of additional host data concurrently, including ecology (host population size and density), serology, incidence and clinical data | • Characterization of capsid stability in the environment to evaluate changes in transmission traits • Synthesis of recombinants carrying each potentially adaptive mutation individually and combinations of mutations to measure epistatic effects and determine mutational pathways[ • Examination of factors affecting adaptation rates by conducting experimental evolution in cell culture | • Examination of multiple isolates sampled longitudinally from reservoir and new host species in the same study • Determination of viral fitness and its link to virulence and the host-jump fitness components by measuring tissue tropism, pathogenicity and virulence[ • Measurement of transmission traits, such as the rate of dissemination to transmission routes and average number of virions available for transmission • Identification of genetic basis of transmission • Measurment of initial viral titre, consensus sequence of genes for many time points and fitness measures of evolved viral populations relative to ancestor during passage (experimental evolution)[ | • Measurement of infectivity–dose relationship for natural routes of infection, of host immune response[ • Infection–transmission experiments with viral genotypes from the reservoir and the new host populations obtained from multiple host jump events, for each genotype in each host and cross-species transmissions (transplant experiments)[ |
|
| |||
• Characterization of viral genotypes that circulate early in an outbreak and their relation to genotypes in the reservoir host by repeated sampling of infected individuals • Intensive sampling of reservoir and new host populations immediately following host jump[ • Sequencing of viral genomes from many reservoir hosts to identify rare fortuitously adapted genotypes[ • Use of genetic data and evolutionary theory to target regions that are hotspots of viral adaptation • Use of next-generation sequencing technology to increase sampling within and between hosts • Collection of clinical data on pathology, infectious period, shedding rates and immune response concurrently with repeated sampling during infection • Integration of genetic and incidence data to determine transmission networks • Sequencing of clones from many time points to link disease characteristics with patterns of genetic variation and transmission networks • Analysis of genetic data from replicate transmission chains to identify sites with convergent evolution[ | • Examination of multiple isolates from both the reservoir and new host species (if possible strains with an estimated transmission chain) for site-directed mutagenesis and phenotypic assays | • Measurement of viral fitness in multiple host individuals to quantify variability in viral fitness and determine sources of the fitness variation • Sequencing of genomes of strains from the evolved populations at many time points during the infection time course and from multiple replicate experimental evolution lines to assess adaptive constraints and repeatability • Measurement of fitness of isolated genotypes from evolved populations to quantify adaptive constraints • Comparison of evolved differences in the presence and absence of selection on transmission using artificial and experimental transmission | • Measurement of viral fitness and host immune response in many host individuals to quantify effects of host heterogeneities (due to innate or adaptive immunity status or host genetics) on viral fitness • Experimental evolution as in the animal experiments and include three types of experimental transmission lineages: reservoir–reservoir, new–new host and cross-species transmission |
| *Steps used to address mechanistic hypotheses in the host jump of influenza A, severe acute respiratory syndrome-coronavirus, canine parvovirus and Venezuelan equine encephalitis virus. Note that the time and financial investment increase from step 1 (sample virus) to step 4 (test in reservoir and new host) negatively correlates with research efforts to date (see Supplementary information S1–S7 (figures)). Earlier steps provide useful groundwork for later steps, and although many techniques are important at multiple steps, they are stated only in the step in which they first become relevant. | |||
Figure 2Origin of strains studied in the surveyed literature.
Articles describing evolutionary data of transmission of influenza virus, severe acute respiratory syndrome-coronavirus (SARS-CoV), canine parvovirus and Venezuelan equine encephalitis virus were grouped into one of the eight categories on the basis of the host origin of the viral strains used for experimentation and/or analyses. Inclusion of multiple strains from multiple hosts is important for a comprehensive experimental design. Numbers indicate the total number of published papers surveyed.
Figure 3Types of relevant data collected by surveyed articles.
The Y axis indicates the number of published papers. Data for all viruses are shown on the left. Dashed lines in right plot indicate the total number of papers for each virus shown. Sequence data refer to sequence analysis of genes, genome or proteins; molecular data refer to viral phenotypes, including antigenicity, receptor binding, genome replication, virion packaging and polymerase binding; kinetic data measure the time course of virion production, reflecting within-host fitness; epidemiological data measure incidence of the virus in the host population; and ecological data refer to environmental conditions, including host movement or contact patterns. Note that articles can fall into more than one category. SARS-CoV, severe acure respiratory syndrome-coronavirus; VEEV, Venezuelan equine encephalitis virus.